Abstract

The global prevalence of diabetes mellitus and other metabolic diseases is rapidly increasing. Animal models play pivotal roles in unravelling disease mechanisms and developing and testing therapeutic strategies. Rodents are the most widely used animal models but may have limitations in their resemblance to human disease mechanisms and phenotypes. Findings in rodent models are consequently often difficult to extrapolate to human clinical trials. To overcome this ‘translational gap’, we and other groups are developing porcine disease models. Pigs share many anatomical and physiological traits with humans and thus hold great promise as translational animal models. Importantly, the toolbox for genetic engineering of pigs is rapidly expanding. Human disease mechanisms and targets can therefore be reproduced in pigs on a molecular level, resulting in precise and predictive porcine (PPP) models. In this short review, we summarize our work on the development of genetically (pre)diabetic pig models and how they have been used to study disease mechanisms and test therapeutic strategies. This includes the generation of reporter pigs for studying beta-cell maturation and physiology. Furthermore, genetically engineered pigs are promising donors of pancreatic islets for xenotransplantation. In summary, genetically tailored pig models have become an important link in the chain of translational diabetes and metabolic research.

Highlights

  • Diabetes mellitus (DM), which is characterized by chronic hyperglycemia, has a high prevalence worldwide

  • In comparison to other large animal species used in diabetes research, such as dogs and non-human primates, pigs have the advantage of better ethical acceptance, relatively low-cost reproduction and maintenance, and the existence of well-established methods for genetic modification

  • We summarize our own experiences with genetically engineered pigs used as models for diabetes and metabolic research or as donors for islet xenotransplantation

Read more

Summary

Introduction

Diabetes mellitus (DM), which is characterized by chronic hyperglycemia, has a high prevalence worldwide. Translational diabetes research is dedicated to improving and developing new diagnostic and therapeutic concepts In this context, pigs are promising animal models due to many anatomical and physiological similarities with humans (Figure 1; reviewed in Aigner et al, 2010; Renner et al, 2016b). In comparison to other large animal species used in diabetes research, such as dogs and non-human primates (reviewed in Kleinert et al, 2018; Ludwig et al, 2020), pigs have the advantage of better ethical acceptance, relatively low-cost reproduction and maintenance, and the existence of well-established methods for genetic modification (reviewed in Renner et al, 2016b). Feeding pigs with high-fat/high-energy diet results in obesity and insulin resistance (Renner et al, 2018), but rarely in clinical diabetes without further interventions

Tailored pig models for diabetes research
The GIPRdn transgenic pig as a model for prediabetes
Metabolic alterations in GHR deficient pigs
Transgenic pigs expressing reporter genes in the pancreatic islets
Genetically modified pig islets for clinical xenotransplantation
Conclusions and perspectives

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.